Approved Business uses its own and third parties’ cookies in order to improve your experience and our services. These cookies provide a better performance, enhanced features and enable certain functionalities. You can obtain more information and learn how to change the configuration of your browser, including how to block some cookies, in our Privacy Policy. However, you should know that blocking some types of cookies may impact your experience on the site and limit the services we are able to offer.

Bioanalytical Protein-Protein Detection with the P4SPR

15 September 2021 | Meritics Ltd

Bioanalytical Protein-Protein Detection with the P4SPR

Approximately one in five women diagnosed with breast cancer worldwide will have HER2-positive breast cancer, a particularly aggressive form of the disease.

Although four diagnostic tests exist, research has shown that some HER2 status test results may still be wrong.

A diagnostic test using SPR may help address some of the current issues.

The potential biosensing application of a new ultra-low fouling ionic liquid is demonstrated using the P4SPR for the analysis of HER2 in breast cancer cell lysates.